Patents by Inventor Ryogo Yui

Ryogo Yui has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING DEPRESSION, NEURODEGENERATION, INHIBITING AMYLOID BETA DEPOSITION, DELAYING SENESCENCE, AND EXTENDING LIFE SPANS WITH HETEROCYCLIC COMPOUNDS
    Publication number: 20140171452
    Abstract: Disclosed is an antidepressant, neuroprotectant, amyloid ? deposition inhibitor, or age retardant composition containing a heterocyclic compound having the general formula (I):
    Type: Application
    Filed: February 12, 2014
    Publication date: June 19, 2014
    Applicant: ZENYAKU KOGYO KABUSHIKI KAISHA
    Inventors: Yoshimasa YAMAGUCHI, Ryogo YUI, Toshiyuki MATSUNO, Kenichi SAITOH, Hitoshi MIYASHITA, Takeshi NAGATA
  • Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
    Patent number: 8338414
    Abstract: A novel method for immunosuppressive in a mammal suffering from an immune disease, including administering to the mammal a therapeutically effective amount of a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is disclosed. A novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is also disclosed.
    Type: Grant
    Filed: May 24, 2010
    Date of Patent: December 25, 2012
    Assignee: Zenyaku Kogyo KabushikiKaisha
    Inventors: Kazuhiko Haruta, Shinichi Yaguchi, Toshiyuki Matsuno, Yoshio Tsuchida, Tetsuo Watanabe, Kimitomo Yoshioka, Ryogo Yui
  • IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
    Publication number: 20100267700
    Abstract: A novel method for immunosuppressive in a mammal suffering from an immune disease, including administering to the mammal a therapeutically effective amount of a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is disclosed. A novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is also disclosed.
    Type: Application
    Filed: May 24, 2010
    Publication date: October 21, 2010
    Applicant: ZENYAKU KOGYO KABUSHIKI KAISHA
    Inventors: Kazuhiko Haruta, Shinichi Yaguchi, Toshiyuki Matsuno, Yoshio Tsuchida, Tetsuo Watanabe, Kimitomo Yoshioka, Ryogo Yui
  • Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
    Patent number: 7750001
    Abstract: A novel method for immunosuppressive in a mammal suffering from an immune disease, including administering to the mammal a therapeutically effective amount of a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is disclosed. A novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is also disclosed.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: July 6, 2010
    Assignee: Zenyaku Kogyo Kabushikikaisha
    Inventors: Kazuhiko Haruta, Shinichi Yaguchi, Toshiyuki Matsuno, Yoshio Tsuchida, Tetsuo Watanabe, Kimitomo Yoshioka, Ryogo Yui
  • IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
    Publication number: 20080113987
    Abstract: A novel method for immunosuppressive in a mammal suffering from an immune disease, including administering to the mammal a therapeutically effective amount of a heterocyclic compound represented by the general formula (I) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is disclosed. A novel heterocyclic compound represented by the general formula (II) (wherein X or other variables are as defined in the specification) or a pharmaceutically acceptable salt thereof is also disclosed.
    Type: Application
    Filed: August 30, 2007
    Publication date: May 15, 2008
    Applicant: ZENYAKU KOGYO KABUSHIKIKAISHA
    Inventors: Kazuhiko Haruta, Shinichi Yaguchi, Toshiyuki Matsuno, Yoshio Tsuchida, Tetsuo Watanabe, Kimitomo Yoshioka, Ryogo Yui
  • METHODS FOR TREATING DELAYING THE PROGRESSION OF ALZHEIMER'S DISEASE WITH HETEROCYCLIC COMPOUNDS
    Publication number: 20080103158
    Abstract: Disclosed is an antidepressant, neuroprotectant, amyloid ? deposition inhibitor, or age retardant composition containing a heterocyclic compound having the general formula (I):
    Type: Application
    Filed: October 15, 2007
    Publication date: May 1, 2008
    Applicant: ZENYAKU KOGYO KABUSHIKI KAISHA
    Inventors: Yoshimasa Yamaguchi, Ryogo Yui, Toshiyuki Matsuno, Kenichi Saitoh, Hitoshi Miyashita, Takeshi Nagata
  • METHODS FOR TREATING DEPRESSION, NEURODEGENERATION, INHIBITING AMYLOID BETA DEPOSITION, DELAYING SENESCENCE, AND EXTENDING LIFE SPANS WITH HETEROCYCLIC COMPOUNDS
    Publication number: 20080103157
    Abstract: Disclosed is an antidepressant, neuroprotectant, amyloid ? deposition inhibitor, or age retardant composition containing a heterocyclic compound having the general formula (I):
    Type: Application
    Filed: October 15, 2007
    Publication date: May 1, 2008
    Applicant: ZENYAKU KOGYO KABUSHIKI KAISHA
    Inventors: Yoshimasa Yamaguchi, Ryogo Yui, Toshiyuki Matsuno, Kenichi Saitoh, Hitoshi Miyashita, Takeshi Nagata